Literature DB >> 18393799

The catalytic core of gamma-secretase: presenilin revisited.

Harald Steiner1.   

Abstract

Mutations in the presenilin 1 (PS1) gene are the major cause of familial Alzheimer s disease (AD). They effect an increased production of the highly neurotoxic 42 amino acid variant of the amyloid-beta peptide (Abeta), which is believed to initiate the disease. Abeta is the product of two consecutive cleavages of the beta-amyloid precursor protein (APP) by two proteases, beta-secretase and gamma-secretase. The latter enzyme has been identified as an intramembrane-cleaving multiprotein complex that apart from APP cleaves a large number of other type I transmembrane proteins. PS1 and its homologue PS2 are essential for gamma-secretase cleavage and more than a decade after their discovery it is now firmly established that they function as catalytic subunits of gamma-secretase. This review recapitulates the findings that led to this conclusion as well as the further progress made on the function of PS as gamma-secretase since then.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393799     DOI: 10.2174/156720508783954677

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  15 in total

1.  Mutation analysis of the presenilin 1 N-terminal domain reveals a broad spectrum of gamma-secretase activity toward amyloid precursor protein and other substrates.

Authors:  Ping Gong; Kulandaivelu S Vetrivel; Phuong D Nguyen; Xavier Meckler; Haipeng Cheng; Maria Z Kounnas; Steven L Wagner; Angèle T Parent; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

2.  Generation of Alzheimer disease-associated amyloid β42/43 peptide by γ-secretase can be inhibited directly by modulation of membrane thickness.

Authors:  Edith Winkler; Frits Kamp; Johannes Scheuring; Amelie Ebke; Akio Fukumori; Harald Steiner
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

3.  Attenuated Abeta42 responses to low potency gamma-secretase modulators can be overcome for many pathogenic presenilin mutants by second-generation compounds.

Authors:  Benedikt Kretner; Akio Fukumori; Amelie Gutsmiedl; Richard M Page; Thomas Luebbers; Guido Galley; Karlheinz Baumann; Christian Haass; Harald Steiner
Journal:  J Biol Chem       Date:  2011-02-25       Impact factor: 5.157

4.  Beta-amyloid precursor protein mutants respond to gamma-secretase modulators.

Authors:  Richard M Page; Amelie Gutsmiedl; Akio Fukumori; Edith Winkler; Christian Haass; Harald Steiner
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

5.  Preventing expression of the nicotinic receptor subunit α7 in SH-SY5Y cells with interference RNA indicates that this receptor may protect against the neurotoxicity of Aβ.

Authors:  Xiao-Lan Qi; Kai Ou-Yang; Jia-Mou Ren; Chang-Xue Wu; Yan Xiao; Yi Li; Zhi-Zhong Guan
Journal:  Neurochem Res       Date:  2013-02-21       Impact factor: 3.996

Review 6.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

7.  Presenilin/gamma-secretase cleaves CD46 in response to Neisseria infection.

Authors:  Nathan J Weyand; Christine M Calton; Dustin L Higashi; Kristen J Kanack; Magdalene So
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

8.  Lactic acid induces aberrant amyloid precursor protein processing by promoting its interaction with endoplasmic reticulum chaperone proteins.

Authors:  Yiwen Xiang; Guilian Xu; Kirsten A K Weigel-Van Aken
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

Review 9.  Intramembrane proteolysis by gamma-secretase.

Authors:  Harald Steiner; Regina Fluhrer; Christian Haass
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

10.  Molecular profiling reveals diversity of stress signal transduction cascades in highly penetrant Alzheimer's disease human skin fibroblasts.

Authors:  Graziella Mendonsa; Justyna Dobrowolska; Angela Lin; Pooja Vijairania; Y-J I Jong; Nancy L Baenziger
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.